{
    "2018-10-08": [
        [
            {
                "time": "2018-10-01",
                "original_text": "Top Biotech Stocks to Buy in October",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Stocks",
                        "Buy",
                        "October"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-02",
                "original_text": "SHAREHOLDER ALERT: SKX PM USAT MCHP ABBV ALNY MGTI CPB CHGG ADNT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines",
                "features": {
                    "keywords": [
                        "SHAREHOLDER",
                        "ALERT",
                        "Class",
                        "Action",
                        "Deadlines"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-03",
                "original_text": "AbbVie's Orilissa Gets Canadian Nod to Treat Endometriosis",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Orilissa",
                        "Canadian",
                        "Nod",
                        "Endometriosis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-04",
                "original_text": "AbbVie's Orilissa Gets Canadian Nod to Treat Endometriosis",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Orilissa",
                        "Canadian",
                        "Nod",
                        "Endometriosis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-05",
                "original_text": "AbbVie to Present New Data for Upadacitinib and HUMIRAÂ® (adalimumab) at the 2018 ACR/ARHP Annual Meeting",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Upadacitinib",
                        "HUMIRA",
                        "Annual",
                        "Meeting"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}